These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 18080921)
1. Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis. Colakoğlu O; Taşkiran B; Colakoğlu G; Kizildağ S; Ari Ozcan F; Unsal B Turk J Gastroenterol; 2007 Dec; 18(4):245-9. PubMed ID: 18080921 [TBL] [Abstract][Full Text] [Related]
2. IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis. Ronsoni MF; Lazzarotto C; Fayad L; Silva MC; Nogueira CL; Bazzo ML; Narciso-Schiavon JL; Dantas-Corrêa EB; Schiavon Lde L Ann Hepatol; 2013; 12(3):456-63. PubMed ID: 23619263 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-3: a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis. Shaarawy M; Fikry MA; Massoud BA; Lotfy S J Clin Endocrinol Metab; 1998 Sep; 83(9):3316-9. PubMed ID: 9745447 [TBL] [Abstract][Full Text] [Related]
4. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma. Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910 [TBL] [Abstract][Full Text] [Related]
5. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Zietz B; Lock G; Plach B; Drobnik W; Grossmann J; Schölmerich J; Straub RH Eur J Gastroenterol Hepatol; 2003 May; 15(5):495-501. PubMed ID: 12702906 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131 [TBL] [Abstract][Full Text] [Related]
7. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance. Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407 [TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068 [TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis. Vyzantiadis T; Theodoridou S; Giouleme O; Harsoulis P; Evgenidis N; Vyzantiadis A Hepatogastroenterology; 2003; 50(51):814-6. PubMed ID: 12828091 [TBL] [Abstract][Full Text] [Related]
10. High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance. Shmueli E; Miell JP; Stewart M; Alberti KG; Record CO Hepatology; 1996 Jul; 24(1):127-33. PubMed ID: 8707251 [TBL] [Abstract][Full Text] [Related]
11. Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma. Rehem RN; El-Shikh WM Hepatogastroenterology; 2011; 58(107-108):949-54. PubMed ID: 21830422 [TBL] [Abstract][Full Text] [Related]
12. Serum insulinlike growth factor-1 and its binding protein-3 levels in children with cirrhosis waiting for a liver transplant. Dehghani SM; Karamifar H; Hamzavi SS; Haghighat M; Malek-Hosseini SA Exp Clin Transplant; 2012 Jun; 10(3):252-7. PubMed ID: 22631062 [TBL] [Abstract][Full Text] [Related]
13. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis. Santolaria F; González-González G; González-Reimers E; Martínez-Riera A; Milena A; Rodgíguez-Moreno F; González-García C Alcohol Alcohol; 1995 Nov; 30(6):703-8. PubMed ID: 8679009 [TBL] [Abstract][Full Text] [Related]
14. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis. Kratzsch J; Blum WF; Schenker E; Keller E Exp Clin Endocrinol Diabetes; 1995; 103(5):285-91. PubMed ID: 8536056 [TBL] [Abstract][Full Text] [Related]
16. The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt. Raslan HM; Elhosary Y; Ezzat WM; Rasheed EA; Rasheed MA Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):429-32. PubMed ID: 20189618 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis. Wu YL; Ye J; Zhang S; Zhong J; Xi RP World J Gastroenterol; 2004 Sep; 10(18):2740-3. PubMed ID: 15309731 [TBL] [Abstract][Full Text] [Related]
18. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis. Assy N; Hochberg Z; Amit T; Shen-Orr Z; Enat R; Baruch Y J Hepatol; 1997 Nov; 27(5):796-802. PubMed ID: 9382965 [TBL] [Abstract][Full Text] [Related]